cytori therapeutics inc (CYTX:NASDAQ GM)
Kenneth R. Chien M.D., Ph.D.
Scientific Advisor,Cytori Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 34 board members in 3 different organizations across 6 different industries.|
See Board Relationships
Prof. Kenneth R. Chien, M.D., Ph.D, has been a Scientific Advisor of Cytori Therapeutics, Inc. (Formerly Macropore Biosurgery Inc). since June 8, 2005. Prof. Chien serves as the Charles R. Sanders Endowed Chair in Medicine at Harvard Medical School. He served as the Director of Cardiovascular Research Center of The General Hospital Corporation (alternative name Massachusetts General Hospital). He co-founded Celladon Corporation in 2000. He served as the Professor of ...
3020 Callan RoadPhone: 858-458-0900
San Diego, California 92121
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robin C. Stracey||Chief Executive Officer and Director|
Cesca Therapeutics Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
Caladrius Biosciences, Inc.
|Dean Tozer||Chief Executive Officer, President and Director|
Nuo Therapeutics, Inc.
|Andrey Semechkin Ph.D.||Co-Chairman and Chief Executive Officer|
International Stem Cell Corporation
|$246.1K||Compensation as of Fiscal Year --.|